Rare Disease Marketing Launch Drives 1800+ Conversions in 3 Months

Adfire Health’s Rare Disease Marketing Campaign Exceeds CPA Goals and Leads to Ongoing DSE and Brand Awareness Management

This image shows a woman in a white lab coat standing outdoors in an urban setting, possibly on a balcony or walkway. She is holding a smartphone in her right hand and a disposable coffee cup in her left hand. The woman appears to be focused on her phone.

The Challenge

Targeting Nephrologists in Rare Disease Campaigns

As a healthcare marketer, navigating the challenges of rare disease marketing is a complex endeavor. When a client approached our team about reaching a highly specialized and niche audience of nephrologists for an unknown kidney disease, Adfire Health devised a strategic niche HCP targeting campaign to successfully increase engagement among their target audience. The disease was not widely recognized, making the audience difficult to target and engage.

Understanding the Barriers in Rare Disease Marketing

Although the rare kidney diseases market1 has significant growth prospects, it faces considerable challenges.2 With small patient populations, limited biomarkers for diagnosis, and intricate care needs, progress is difficult. High development costs, struggles with patient recruitment for clinical trials, and a lack of FDA-approved treatments add to the obstacles.3 Even with the U.S. Orphan Drug Act4 providing incentives like tax credits and market exclusivity, 95% of rare diseases still lack approved therapies.

That said, the market is making strides. Increasing awareness, innovations in diagnosis and treatment, and collaboration among major stakeholders like Calliditas Therapeutics, GSK, Aurinia Pharmaceuticals, and Amicus Therapeutics are fueling growth.2 The market is forecasted to grow from $3.9 billion in 2024 to $12.1 billion by 2035, with a compound annual growth rate (CAGR) of 11%.5

Adfire Health’s client faced similar marketing hurdles, struggling to develop strong nephrologist engagement strategies. By collaborating with Adfire Health, our client was able to effectively reach their target audience, raising awareness about this little-known kidney disease and spotlighting advancements in diagnostic techniques and emerging therapeutic options.

Let’s explore the specific rare disease kidney marketing tactics Adfire Health deployed to help our client gain traction in the industry.

The Solution

Engaging Nephrologists with Strategic Rare Disease Marketing Strategies

Our client was up against the difficult challenge of reaching a specific demographic of nephrologists to educate them about a rare kidney disease. They sought a strategic solution to effectively engage HCPs and raise awareness. Adfire Health addressed this need by developing a comprehensive rare disease marketing campaign using a multi-faceted approach to enhance our client’s healthcare marketing efforts.

Crafting a Tailored 1:1 Display Campaign for Rare Diseases

Our client aimed to improve CPA efficiency by increasing awareness and engagement among nephrologists focused on a specific kidney disease. Adfire Health crafted a 1:1 display campaign to precisely target nephrologists, maximizing reach through strategic digital ad formats and placements. Our team developed tailored messaging for these display ads, ensuring delivery across multiple devices to maintain consistent engagement and awareness. Adfire Health then employed advanced data analytics to identify responsive HCP segments and dynamically optimize the campaign in real-time.

Aligning Cross-Platform Strategies for Rare Disease Marketing Efforts

By using advanced analytics to understand neurologists’ online behaviors, professional interests, and the latest industry trends, Adfire Health ensured that ad messaging followed the target HCP audience across their professional and personal devices, creating a cohesive experience. We also leveraged medical and healthcare apps where nephrologists are likely to engage, providing contextually relevant ads. The approach enhanced engagement by connecting nephrologists with content through their preferred digital platforms and channels.

Retargeting Nephrologists to Capture HCP Interest

Adfire Health employed HCP retargeting to maintain and enhance interest in learning about this rare kidney disease, fostering ongoing engagement among healthcare professionals and driving more impactful campaign interactions. By re-engaging nephrologists who showed interest but did not convert immediately, our retargeting strategy increased the chances of conversion. The strategy ensured the rare kidney disease campaign remained prominent by staying active in the online spaces preferred by specialists.

The Results

Targeted HCP Campaign Increases Nephrologist Awareness of Available Treatments

Generated 1800+ Conversions in 3 Months

Adfire Health effectively engaged nephrologists through cross-device targeting, in-app targeting, and creative retargeting. Within 3 months, our healthcare campaign yielded more than 1,800 conversions, surpassing client expectations.

Exceeded the Client’s CPA Achievement Goal

Adfire Health’s rare disease marketing campaign exceeded our client’s CPA goals, leading to increased engagement from nephrologists. Nephrologist engagement metrics showed a $29.97 CPA. For rare diseases, where the target audience is more niche and specialized, the CPA can be higher compared to more common conditions due to the challenges in reaching and engaging the right audience.

Produced Successful Client Feedback in HCP Campaigns

The success of our rare disease marketing campaign led to a stronger partnership, with the client expressing, “You’re one of our top performers on the HCP campaign.” This success allowed us to expand our efforts into building awareness for rare diseases and managing Disease State Education (DSE) campaign, ultimately helping to better inform nephrologists and patients about treatment options and advancing the push for improved care.

At Adfire Health, we work with healthcare marketers to create optimized, highly effective, data-based digital engagement strategies. With Thumbprint™, our segmented data ecosystem of over 8.2 million healthcare professionals, we can offer direct access to healthcare professionals nationwide.

We bring years of hands-on experience to every new campaign and work with you to get the best results possible. Contact us to learn more about what we can do for your business.

Refine Your Healthcare Campaign Strategies with Adfire Health

FAQ

What is niche HCP targeting, and why is it important in rare disease marketing?

Niche HCP targeting refers to the practice of focusing marketing efforts on a specific group of healthcare professionals (HCPs) who are most relevant to a particular condition or treatment, such as nephrologists for a rare kidney disease. This approach is crucial in rare disease marketing because it allows for more personalized and effective communication, ensuring that the message reaches the right audience who can influence patient outcomes.

How does a 1:1 display campaign work in healthcare marketing?

A 1:1 display campaign involves delivering personalized advertisements to individual HCPs across multiple devices. This strategy ensures that the messaging is consistent and relevant, following the HCPs as they navigate different digital environments. In healthcare marketing, this is particularly effective for building awareness and engagement among niche audiences.

What are the benefits of using cross-device marketing in a healthcare campaign?

Cross-device marketing allows marketers to reach HCPs across their various devices, whether they are using a computer, tablet, or smartphone. The benefits include maintaining a consistent brand message, increasing the chances of engagement by meeting HCPs where they spend their time, and providing a seamless experience that reinforces the campaign's objectives.

How does retargeting enhance the effectiveness of rare disease campaigns?

Retargeting involves re-engaging HCPs who have previously interacted with the campaign but have not yet converted. This tactic is particularly useful in rare disease campaigns because it keeps the disease and treatment options top of mind, encouraging HCPs to take action or seek more information after initial exposure.

Why is in-app advertising a valuable tactic for reaching HCPs?

In-app advertising allows marketers to place ads within mobile applications commonly used by HCPs, such as medical reference apps or healthcare-related tools. This contextually relevant placement ensures that the ads are seen by a highly targeted audience when they are most engaged, increasing the likelihood of conversion.

What role does data-driven marketing play in reaching niche HCP audiences?

Data-driven marketing uses analytics and data insights to identify the most responsive segments within a niche HCP audience. This approach allows for more precise targeting, optimizing the campaign in real-time to improve engagement and conversion rates. It also helps in making informed decisions about where to allocate resources for maximum impact.

How do you measure the success of a healthcare marketing campaign focused on CPA?

The success of a CPA (Cost Per Acquisition) focused campaign is measured by the cost-effectiveness of acquiring a new customer or lead. In healthcare marketing, this might include tracking the cost associated with each nephrologist who takes a desired action, such as signing up for more information, attending a webinar, or prescribing a treatment. Lowering the CPA while maintaining high engagement levels is a key indicator of success.

What are Disease State Education (DSE) campaigns, and how do they fit into broader marketing strategies?

Disease State Education (DSE) campaigns are designed to educate HCPs and patients about a particular disease, its symptoms, and treatment options. In rare disease marketing, DSE campaigns are critical for raising awareness and providing important information that might not be widely known. These campaigns often complement broader marketing strategies by building a foundational understanding that supports other promotional efforts.

How can a healthcare marketing agency scale its efforts after a successful campaign?

After a successful campaign, a healthcare marketing agency can scale its efforts by expanding the scope of services offered, such as taking on brand awareness campaigns, managing DSE initiatives, or increasing the budget to reach a larger audience. Continuous optimization, leveraging successful strategies, and maintaining a strong client relationship are key to scaling effectively.

Sources

  1. Roots Analysis. (n.d.). Rare disease kidney market.
    https://www.rootsanalysis.com/reports/rare-kidney-diseases-market.html
  2. Transparency Market Research. (2022, November). Rare kidney diseases treatment market.
    https://www.transparencymarketresearch.com/rare-kidney-diseases-treatment-market.html
  3. SkyQuest. (2024, March). Rare disease treatment market size, share, growth analysis, by route of administration (oral, injectable, and others), by drug (biologics, biosimilar, and small molecule), by region – Industry forecast 2024-2031.
    https://www.skyquestt.com/report/rare-disease-treatment-market
  4. Congressional Research Service. (2024, March 5). The Orphan Drug Act: Legal Overview and Policy Considerations.
    https://crsreports.congress.gov/product/pdf/IF/IF12605/2
  5. Research And Markets. (2024, May). Rare kidney diseases market: Industry trends and global forecasts, till 2035: Distribution by target disease indications, type of molecule, type of biologics, route of administration, type of therapy, key geographical regions, leading drug developers and sales forecast.
    https://www.researchandmarkets.com/reports/5691620/rare-kidney-diseases-market-industry-trends-and?utm_source=GNE&utm_medium=PressRelease&utm_code=hhgdlz&utm_campaign=1986194+-+Rare+Kidney+Diseases+Market+Report+2024+to+2035%2c+by+Target+Indications%2c+Type+of+Molecule%2c+Route+of+Administration+and+Key+Geographies&utm_exec=carimspi

How can we help your marketing?

=